01
Molecular diagnostics
Application of nucleic-acid based technologies — including PCR and sequencing-related workflows — to detect and characterize pathogens and disease markers.
Diagnostics Leadership
From portfolio strategy to laboratory workflow.
Diagnostics leadership across molecular assays, immunodiagnostics and clinical chemistry — spanning product lifecycle, launch strategy, laboratory workflow assessment and stakeholder engagement in regulated environments.
Areas of practice
02
Laboratory workflow and testing pathways
Assessment and optimization of laboratory workflows, sample flow, testing pathways and centralized diagnostic operations.
03
Portfolio strategy and product lifecycle
Definition and management of the diagnostic portfolio across the full product lifecycle, from evaluation to end-of-life.
04
Launch and market readiness
Regional and international launch strategy for assays and analyzers, including scientific and commercial readiness.
05
Stakeholder and expert engagement
Collaboration with laboratories, clinical experts, key accounts, distributors and healthcare stakeholders.
06
Business case development
Building the scientific, clinical, operational and commercial case for the adoption of advanced diagnostic technologies.
07
Training and capability building
Scientific and commercial training programs supporting the correct use, positioning and value communication of diagnostic solutions.
08
Regulated quality environments
Work under regulated quality-system environments applicable to in vitro diagnostic organizations.